Behandling af den ældre patient med hæmatologisk kræft

Translated title of the contribution: Treatment of the elderly patient with haematological cancer

Nina Andersen, Ahmed Ludvigsen Al-Mashadi, Emelie Hamotal Curovic Rotbain, Ida Bruun Kristensen, Tine Bichel Lauritsen, Christian Bjørn Poulsen, Hans Beier Ommen, Christen Bertel Lykkegaard Andersen, Tarec Christoffer El-Galaly, Niels Abildgaard*

*Corresponding author for this work

Research output: Contribution to journalJournal articleResearchpeer-review

40 Downloads (Pure)

Abstract

During the last two decades, novel targeted therapies, in particular, »small molecules« for oral administration and monoclonal antibodies, have revolutionized the treatment and prognosis of haematological cancers. Generally, these treatments are well tolerated and therefore suitable for elderly patients. This review presents a short update on the current standard-of-care treatment of elderly patients with haematological cancer.
Translated title of the contributionTreatment of the elderly patient with haematological cancer
Original languageDanish
Article numberV08230538
JournalUgeskrift for Læger
Volume186
Issue number2
ISSN0041-5782
DOIs
Publication statusPublished - 22. Jan 2024

Fingerprint

Dive into the research topics of 'Treatment of the elderly patient with haematological cancer'. Together they form a unique fingerprint.

Cite this